.gif "IP Gear")
Has anyone else seen information on this supplement bill that Hillary Clinton is backing??
Senate Bill 722 is part of a larger problem that we will
continue to face as we go forward. The House Commerce
Committee recently held meetings. One of the topics of
discussion was all of the ephedra law suits complaints and
legislation. The growing consensus among the members of the
committee that DSHEA will have to be revisited. This
renewed microscope on dietary supplements is the result of
the ephedra issues in the press and all the Federal Trade
Commission (FTC) and FDA actions that have been taken
lately against companies making outrageous claims about
products. The biggest concern comes from the fact that the
people on the left in the Senate and the Right in the house
seem to be favoring stronger controls and regulation on our
industry. Having both sides raising concerns is a bad
formula for all of us. We are going to have to stay on top
of it. It looks like we are going to be in for a battle as
all of these issues unfold this bill is probably just the
beginning.
Under the Durbin Bill, if a single report of an adverse
experience occurring while taking a dietary supplement is
received, even though it is not known to be casually
related to the dietary supplement, the FDA can initiate
procedures resulting in the termination of the marketing of
the ingredient. All these procedures are left to the
unbridled discretion and whim of the FDA.
Already, adverse experiences have been filed with the FDA
for:
Vitamin C
Echinacea
Calcium
Multivitamins
Glucosamine
And more
If this bill passes, anyone who is tied to a company that
makes a product that competes with a dietary supplement can
make a complaint. Then the FDA can suddenly decide that the
product is no longer safe, and order it removed from the
market. What, you don't think the FDA will bow to pressure
from the agro-pharma industry to get rid of good healthy
products that can reduce your use and doctors prescribing
pharma's products? You don't think the FDA would stoop to
that level?
There is a link for a letter to send.. but, not sure if all this is accurate.. any other info guys??
Senate Bill 722 is part of a larger problem that we will
continue to face as we go forward. The House Commerce
Committee recently held meetings. One of the topics of
discussion was all of the ephedra law suits complaints and
legislation. The growing consensus among the members of the
committee that DSHEA will have to be revisited. This
renewed microscope on dietary supplements is the result of
the ephedra issues in the press and all the Federal Trade
Commission (FTC) and FDA actions that have been taken
lately against companies making outrageous claims about
products. The biggest concern comes from the fact that the
people on the left in the Senate and the Right in the house
seem to be favoring stronger controls and regulation on our
industry. Having both sides raising concerns is a bad
formula for all of us. We are going to have to stay on top
of it. It looks like we are going to be in for a battle as
all of these issues unfold this bill is probably just the
beginning.
Under the Durbin Bill, if a single report of an adverse
experience occurring while taking a dietary supplement is
received, even though it is not known to be casually
related to the dietary supplement, the FDA can initiate
procedures resulting in the termination of the marketing of
the ingredient. All these procedures are left to the
unbridled discretion and whim of the FDA.
Already, adverse experiences have been filed with the FDA
for:
Vitamin C
Echinacea
Calcium
Multivitamins
Glucosamine
And more
If this bill passes, anyone who is tied to a company that
makes a product that competes with a dietary supplement can
make a complaint. Then the FDA can suddenly decide that the
product is no longer safe, and order it removed from the
market. What, you don't think the FDA will bow to pressure
from the agro-pharma industry to get rid of good healthy
products that can reduce your use and doctors prescribing
pharma's products? You don't think the FDA would stoop to
that level?
There is a link for a letter to send.. but, not sure if all this is accurate.. any other info guys??
